Legumain Knockout Protects Against Aβ1-42-Induced AD-like Cognitive Deficits and Synaptic Plasticity Dysfunction Via Inhibiting Neuroinflammation Without Cleaving APP Article

Chen, Runwen, Zhang, Qiyue, Yan, Yuxing et al. (2021). Legumain Knockout Protects Against Aβ1-42-Induced AD-like Cognitive Deficits and Synaptic Plasticity Dysfunction Via Inhibiting Neuroinflammation Without Cleaving APP . MOLECULAR NEUROBIOLOGY, 58(4), 1607-1620. 10.1007/s12035-020-02219-3

cited authors

  • Chen, Runwen; Zhang, Qiyue; Yan, Yuxing; Zhang, Yuying; Zhang, Tao

sustainable development goals

authors

publication date

  • April 1, 2021

published in

keywords

  • ALZHEIMERS-DISEASE
  • ASPARAGINE ENDOPEPTIDASE
  • Alzheimer's disease
  • CEREBROSPINAL-FLUID
  • Cognitions
  • INFLAMMATION
  • INNATE
  • Legumain
  • Life Sciences & Biomedicine
  • MEMORY
  • MICROGLIA
  • NEURODEGENERATION
  • Neuroinflammation
  • Neurosciences
  • Neurosciences & Neurology
  • PATHWAY
  • RECEPTOR
  • Science & Technology
  • Synaptic plasticity

Digital Object Identifier (DOI)

publisher

  • SPRINGER

start page

  • 1607

end page

  • 1620

volume

  • 58

issue

  • 4